Anti-Cyclin D1 antibody [SP4] (Ab16663)
BCL1, PRAD1, CCND1, G1/S-specific cyclin-D1, B-cell lymphoma 1 protein, BCL-1 oncogene, PRAD1 oncogene, BCL-1
详细信息
背景信息
This product was switched from a hybridoma to recombinant production method on 22nd January 2019. Product Specifications Anti-Cyclin D1 antibody [SP4] (ab16663) was developed by Abcam using patented rabbit monoclonal antibody technology and is validated for use in Flow Cyt (Intra), ICC/IF, IHC-P, WB in human, mouse, rat samples. Anti-Cyclin D1 antibody [SP4] (ab16663) specifically detects Cyclin D1 (UniProt ID: P24385; Molecular weight: 34kDa) and is sold in 100 µL, 500 µL and 1 mL selling sizes. Anti-Cyclin D1 antibody [SP4] (ab16663) is a clone from the portfolio of Spring Bioscience (Roche) SP clones which have been optimised for immunohistochemistry (IHC). Quality and Validation Abcam's high quality manufacturing and validation processes ensure Anti-Cyclin D1 antibody [SP4] (ab16663) has high sensitivity and specificity alongside high lot-to-lot consistency and reproducibility. The specificity of Anti-Cyclin D1 antibody [SP4] (ab16663) has been confirmed by testing in knockout samples. Anti-Cyclin D1 antibody [SP4] (ab16663) has been cited over 559 times in peer reviewed journals and is trusted by the scientific community. Anti-Cyclin D1 antibody [SP4] (ab16663) has 23 independent reviews from customers. Related Products Antibody clone SP4 is also available pre-conjugated to a variety of labels for your convenience - Alexa Fluor® 647 ( ab267515 ). Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents. What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies.
文献引用 (654)
Isoliensinine inhibits mitophagy and sensitizes T cell malignancies for STING-mediated NK clearance.
异莲心碱抑制线粒体自噬,使 T 细胞恶性肿瘤对 STING 介导的 NK 清除更加敏感。
HMGB1 mediates low-dose ionizing radiation-induced Wnt/β-catenin activation in SRA01/04 cells: Mechanistic clues to early cataractogenesis.
HMGB1介导低剂量电离辐射诱导的SRA01/04细胞中Wnt/β-catenin激活:早期白内障发生的机制线索。
Low, plasma levelâinformed native curcumin concentrations fail to induce cell death in human lung and colorectal cancer cells.
血浆浓度较低的天然姜黄素浓度无法诱导人类肺癌和结直肠癌细胞死亡。
Pathophysiology of androgen-associated endothelial cell dysfunction in phenotype A polycystic ovarian syndrome revealed by iPSCs modeling.
利用 iPSCs 模型揭示 A 型多囊卵巢综合征中雄激素相关内皮细胞功能障碍的病理生理学。
TPST2-mediated tyrosine sulfation orchestrates porcine preimplantation development.
TPST2介导的酪氨酸硫酸化调控猪胚胎植入前发育。
Overexpression of Transferrin Receptor in Esophageal Squamous Cell Cancer Suggests Poor Prognosis and Potential Therapy.
食管鳞状细胞癌中转铁蛋白受体的过度表达提示预后不良和潜在治疗。
ZNF282 Promotes Colorectal Cancer Progression Possibly via E2F1 Activation.
ZNF282 可能通过 E2F1 激活促进结直肠癌进展。
Bone mesenchymal stem cells-derived exosomal miR-509-5p promotes osteogenic differentiation by targeting SFRP1 and activating the Wnt/β-catenin pathway.
骨髓间充质干细胞来源的外泌体 miR-509-5p 通过靶向 SFRP1 并激活 Wnt/β-catenin 通路促进成骨分化。
ppAT drives glutamine-dependent purine biosynthesis and malignant progression in hepatocellular carcinoma.
ppAT 驱动谷氨酰胺依赖性嘌呤生物合成和肝细胞癌的恶性进展。
Inhibition of TLR4 enhances oxaliplatin chemotherapy sensitivity in esophageal squamous cell carcinoma by suppressing inflammation and glycolysis.
抑制 TLR4 可抑制炎症和糖酵解,从而增强食管鳞状细胞癌对奥沙利铂化疗的敏感性。
- 1
- 2
- 3
- 4
- 5
- 6
- 66